Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.043 AUD -2.27% Market Closed
Updated: May 19, 2024
PTX
/
Income Statement
/
Income from Continuing Operations

Prescient Therapeutics Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prescient Therapeutics Ltd
Income from Continuing Operations Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Prescient Therapeutics Ltd
ASX:PTX
Income from Continuing Operations
-AU$7.7m
CAGR 3-Years
-31%
CAGR 5-Years
-21%
CAGR 10-Years
-21%
Immutep Ltd
ASX:IMM
Income from Continuing Operations
-AU$40.5m
CAGR 3-Years
-14%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Mesoblast Ltd
ASX:MSB
Income from Continuing Operations
-$73.1m
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Income from Continuing Operations
$2.5B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
7%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Income from Continuing Operations
AU$30.2m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Income from Continuing Operations
AU$5.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Prescient Therapeutics Ltd's Income from Continuing Operations?
Income from Continuing Operations
-7.7m AUD

Based on the financial report for Dec 31, 2023, Prescient Therapeutics Ltd's Income from Continuing Operations amounts to -7.7m AUD.

What is Prescient Therapeutics Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-21%

Over the last year, the Income from Continuing Operations growth was -44%. The average annual Income from Continuing Operations growth rates for Prescient Therapeutics Ltd have been -31% over the past three years , -21% over the past five years , and -21% over the past ten years .

ALPHA SPREAD
Join more than 138,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.